Screener
Alnylam Pharmaceuticals ALNY Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) per common share — basic | $1.23 | $(0.55) | $2.78 | $(0.70) |
| Net income (loss) per common share — diluted | $1.21 | $(0.55) | $2.71 | $(0.70) |
| Weighted-average common shares — basic | 133,606 | 130,628 | 133,244 | 130,155 |
| Weighted-average common shares — diluted | 138,281 | 130,628 | 138,249 | 130,155 |
| Statements of Comprehensive Income (Loss) | ||||
| Net income (loss) | $164,494 | $(72,228) | $370,485 | $(90,479) |
| Other comprehensive (loss) income: | ||||
| Unrealized (losses) gains on marketable securities | (3,635) | (343) | (7,287) | 687 |
Cover / Front Matter
FAQ
- What is Alnylam Pharmaceuticals's shares (diluted)?
- Alnylam Pharmaceuticals (ALNY) reported shares (diluted) of 138.3M in Q2 2026.
- How has Alnylam Pharmaceuticals's shares (diluted) changed year-over-year?
- Alnylam Pharmaceuticals's shares (diluted) increased by 5.9% year-over-year, from 130.6M to 138.3M.
- What is the long-term trend for Alnylam Pharmaceuticals's shares (diluted)?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's shares (diluted) has grown at a 3.0% compound annual growth rate (CAGR), from 472.4M to 532.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Alnylam Pharmaceuticals's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude